Diversity of Pharmacological Strategies for Atherosclerosis: Impact of Atorvastatin, Ezetimibe, Lisinopril, Telmisartan and Allopurinol - Haidar Jawad - Livros - LAP LAMBERT Academic Publishing - 9783848449446 - 10 de maio de 2012
Caso a capa e o título não sejam correspondentes, considere o título como correto

Diversity of Pharmacological Strategies for Atherosclerosis: Impact of Atorvastatin, Ezetimibe, Lisinopril, Telmisartan and Allopurinol

Haidar Jawad

Preço
€ 74,99

Item sob encomenda (no estoque do fornecedor)

Data prevista de entrega 10 - 22 de jul
Adicione à sua lista de desejos do iMusic

Diversity of Pharmacological Strategies for Atherosclerosis: Impact of Atorvastatin, Ezetimibe, Lisinopril, Telmisartan and Allopurinol

Atherosclerosis and its complications are responsible for about 40% of deaths in the developed world and for about 30% of fatalities in developing nations. However, despite the consistent effects of lipid-lowering medications in reducing cardiovascular morbidity and mortality, the reductions in clinical events remain modest, ranging from 25 to 35%. In addition to lipid modification, blockade of renin angiotensin system, reduction of oxidative stress, augmentation of nitric oxide availability, reduction of Ca2+ influx as well as attenuation of inflammation, platelet activation, smooth muscle cells proliferation and stabilization of plaque have been recognized as emerging targets for drug treatment to control the development and progression of the atherosclerotic disease process. This book emphasises on anti-atherosclerotic potential of diverse drugs namely atorvastatin, ezetimibe, lisinopril, telmisartan and allopurinol.

Mídia Livros     Paperback Book   (Livro de capa flexível e brochura)
Lançado 10 de maio de 2012
ISBN13 9783848449446
Editoras LAP LAMBERT Academic Publishing
Páginas 172
Dimensões 150 × 10 × 226 mm   ·   258 g
Idioma English  

Ver tudo de Haidar Jawad ( por exemplo Paperback Book )